APA (7th ed.) Citation

Sroczynski, G., Esteban, E., Widschwendter, A., Oberaigner, W., Hintringer, K., Endel, G., & Siebert, U. (2016). PMD55 - Cost-Effectiveness of Different Cervical Cancer Primary Screening Using Cytology, HPV Or P16/KI-67 Testing Alone Or in Combinations for The Austrian Health Care Context. Value in Health, 19(7), A694. https://doi.org/10.1016/j.jval.2016.09.1996

Chicago Style (17th ed.) Citation

Sroczynski, G., E. Esteban, A. Widschwendter, W. Oberaigner, K. Hintringer, G. Endel, and U. Siebert. "PMD55 - Cost-Effectiveness of Different Cervical Cancer Primary Screening Using Cytology, HPV Or P16/KI-67 Testing Alone Or in Combinations for The Austrian Health Care Context." Value in Health 19, no. 7 (2016): A694. https://doi.org/10.1016/j.jval.2016.09.1996.

MLA (9th ed.) Citation

Sroczynski, G., et al. "PMD55 - Cost-Effectiveness of Different Cervical Cancer Primary Screening Using Cytology, HPV Or P16/KI-67 Testing Alone Or in Combinations for The Austrian Health Care Context." Value in Health, vol. 19, no. 7, 2016, p. A694, https://doi.org/10.1016/j.jval.2016.09.1996.